Search

Search Constraints

You searched for: Author/Creator Hanna, Gerard

Search Results

2. Baseline cardiovascular disease and risk of cardiac events following radical radiotherapy in NSCLC. (April 2023)

3. HALT: targeted therapy with or without dose-intensified radiotherapy in oligo-progressive disease in oncogene addicted lung tumours. (June 2021)

4. HALT: targeted therapy with or without dose-intensified radiotherapy in oligo-progressive disease in oncogene addicted lung tumours. (March 2022)

6. Reflex PDL-1 testing for all NSCLC stages and clinical outcomes: the Northern Irish Experience 2017–2021. (March 2022)

7. SARON: stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer (NSCLC). (March 2022)

8. Single-arm prospective interventional study assessing feasibility of using gallium-68 ventilation and perfusion PET/CT to avoid functional lung in patients with stage III non-small cell lung cancer. Issue 12 (10th December 2020)

9. Single-arm prospective interventional study assessing feasibility of using gallium-68 ventilation and perfusion PET/CT to avoid functional lung in patients with stage III non-small cell lung cancer. Issue 12 (10th December 2020)

10. Single-arm prospective interventional study assessing feasibility of using gallium-68 ventilation and perfusion PET/CT to avoid functional lung in patients with stage III non-small cell lung cancer. Issue 12 (10th December 2020)